CMB 573Biotechnology Product Evaluation and Development

University of Rhode Island · GRAD

Catalog

(3 crs.) Cross-listed as BTC571/CMB573. Examines the process through which candidate products produced using recombinant DNA technology are evaluated for safety and efficacy, including conductance of clinical trials, economic issues, and regulatory affairs. (Lec. 3/Online) Pre: graduate standing and permission of chairperson.

Recent sections

Fall 2026 · 1 section

Sep 9 – Dec 14

Section	Days & time	Location	Instructor
0001-LECClass #6866	Time not published	Online Asynchronous	Brian Plouffe